DL-threo-Droxidopa

• CAT Number: R046746
• CAS Number: 3916-18-5
• Molecular Formula: C9H11NO5
• Molecular Weight: 213.19
• Purity: ≥95%
• Synonyms: (βS)-rel-β,3-Dihydroxy-D-tyrosine; DL-threo-3-(3,4-Dihydroxyphenyl)serine; DL-DOPS; L-Threodops; DL-threo-3,4-Dihydroxyphenylserine; DL-threo-DOPS; threo-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic Acid
• Storage: -20°C
• IUPAC Name: (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid
• InChI: InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1
• InChIKey: QXWYKJLNLSIPIN-JGVFFNPUSA-N
• SMILES: C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O

DL-threo-Droxidopa(CAT: R046746) is a synthetic catecholamine precursor widely utilized in pharmaceutical and biochemical research. Structurally related to norepinephrine, this compound is commonly studied for its role in neurological pathways and its potential therapeutic applications, particularly in treating conditions like neurogenic orthostatic hypotension and Parkinson’s disease. As a racemic mixture, DL-threo-Droxidopa serves as a versatile tool for investigating catecholamine metabolism, neurotransmitter synthesis, and receptor interactions. With excellent purity and stability, it is a reliable compound for advanced research in neurobiology, drug development, and biochemical studies.